Cargando…
Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
Long noncoding RNAs (lncRNAs) have recently emerged as new potentially promising therapeutic targets in many cancers. However, their prognostic value and biological functions associated with glioma remain to be elucidated. Here, High-throughput RNAseq was performed to detect the expression profiles...
Autores principales: | Wu, Fan, Zhang, Chuanbao, Cai, Jinquan, Yang, Fan, Liang, Tingyu, Yan, Xiaoyan, Wang, Haoyuan, Wang, Wen, Chen, Jing, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581096/ https://www.ncbi.nlm.nih.gov/pubmed/28881797 http://dx.doi.org/10.18632/oncotarget.18162 |
Ejemplares similares
-
Upregulation of long noncoding RNA SPRY4‐IT1 correlates with tumor progression and poor prognosis in cervical cancer
por: Cao, Yang, et al.
Publicado: (2016) -
Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment
por: Qin, Jie, et al.
Publicado: (2021) -
Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer
por: Liu, Zhili, et al.
Publicado: (2017) -
Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer
por: Zhang, Cheng, et al.
Publicado: (2017) -
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)